Vaccinex, Inc.
(NASDAQ : VCNX)

( )
VCNX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.08%196.181.2%$557.67m
TSROTESARO, Inc.
0.22%74.2514.4%$534.38m
CELGCelgene Corporation
1.18%69.491.2%$528.88m
GILDGilead Sciences, Inc.
0.34%67.720.9%$508.18m
BIIBBiogen Inc.
0.11%319.791.3%$358.06m
ILMNIllumina, Inc.
1.81%328.903.5%$353.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.50%375.722.6%$262.39m
AAgilent Technologies, Inc.
0.67%71.061.5%$237.22m
VRTXVertex Pharmaceuticals Incorporated
-0.32%173.231.9%$235.67m
ALXNAlexion Pharmaceuticals, Inc.
0.16%114.832.0%$143.36m
SRPTSarepta Therapeutics, Inc.
1.79%125.0015.4%$112.54m
INCYIncyte Corporation
0.28%65.602.5%$104.06m
EXASExact Sciences Corporation
-0.04%69.5225.3%$99.67m
NKTRNektar Therapeutics
-0.63%36.435.5%$97.21m
EXELExelixis, Inc.
-1.78%20.986.4%$82.17m

Company Profile

Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. It focuses on developing antibody treatments relevant to cancer, inflammation, and auto-immune diseases, as well as products for the treatment of non-small cell lung cancer, osteosarcoma, melanoma and Huntington's diseases. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.